Global ECG Telemetry Devices Market - Segmented by uses, application and geography 2017 - 2022

  • ID: 4388381
  • Report
  • Region: Global
  • 205 pages
  • Mordor Intelligence
1 of 3
The global market for ECG devices has been estimated at USD XX billion in 2015 and is projected to reach USD XX billion by 2020, at a CAGR of X% in the forecast period from 2015 to 2021. ECG is a diagnostic tool used to measure the electrical and muscular functions of the heart. This is done by placing electrodes on patient’s body over a period of time.

ECG is used in cases of patients with suspected heart attack, suspected pulmonary embolism, cardiac murmur, cardiac dysrhythmias, and for monitoring the effects of cardiac medications. It is used in hospitals, clinics and in home settings.

The global ECG devices market is driven by the rise in number of life style related disorders, and ageing demographic. However, the market is constrained due to the lack of skilled personnel to handle monitoring devices and uncertain reimbursement policies.

The global ECG devices market has been segmented by product type: monitoring ECG systems, and diagnostic ECG systems; by portability: portable ECG and wireless ECG; by lead type: single lead ECG, 3-6 lead ECG, and 12 lead ECG; and by end user: home based users, clinics and hospitals.

The global ECG devices market has been geographically segmented into Asia Pacific, Europe, Middle East and North Africa (MENA), North America, and Rest of the World, with North America dominating the market. Asia Pacific is also an emerging market which has a scope for growth and can potentially dominate the market in the future.

The use of ECGs in wearable technology devices has opened growth opportunities for brain monitoring devices globally. The major companies dominating the market with its products, services and continuous product developments are Philips Healthcare, GE Healthcare, Schiller, Cardiac Sciences Corp, Midmark, and Bionet. However, the global ECG devices market is challenged by pricing pressure and competition.

Key Deliverables:

Market analysis for the global ECG devices market, with region specific assessments and competition analysis on global and regional scales.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market shares.
Identification and analysis of the macro and micro factors that affect the global ECG devices market on both global and regional scales.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1 Report description
1.2 Research Methodology
2. Executive Summary
3. Market Overview
3.1 Market Definitions
3.2 Market Drivers
3.2.1 Homecare monitoring devices
3.2.2 Increase in cardiovascular diseases rates
3.2.3 Increase in number of service providers
3.3 Market Restraints
3.3.1 Cost constraint
3.3.2 Continous need of communication wireless mode
3.3.3 emerging economies
3.4 Market opportunities
3.5 Market threats
4. Portors five force analysis
4.1 Bargaining Power of suppliers
4.2 Bargaining power of buyers
4.3 Degree of competition
4.4 Threat of substitution
4.5 Threat of new entrants
5. Market segmentation
5.1 By uses
5.1.1 suspected heart attack
5.1.2 suspected pulmonary embolism
5.1.3 A cardiac murmur
5.1.4 Perceived cardiac dysrhythmias
5.1.5 Monitoring the effects of a heart medication
5.2 By applications
5.2.1 Arrhythmias
5.2.2 Disorders in the activation sequence
5.2.3 Increase in wall thickness or size of the atria and ventricles
5.2.4 Myocardial ischemia and infarction
5.2.5 Drug effect
5.2.6 Electrolyte imbalance
5.2.7 Carditis
5.2.8 Pacemaker monitoring
5.3 By Geography
5.3.1 North America U.S.A Canada Mexico
5.3.2 Europe France Germany United Kingdom Scandinavia
5.3.3 Asia Pacific China India Japan Australia Singapore
5.3.4 LAMEA Latin America Middle East Africa
6. Competitive Landscape
6.1 Mergers and Acquisitions
6.2 Agreements, Collaborations and Partnerships
6.3 New product launches
6.4 Recommendations to new market players
7. Company Profiles
7.1 Aerotel Medical Systems Ltd.
7.2 Cardiac Science Corporation
7.3 Nihon Kohden Corporation
7.4 Philips Healthcare
7.5 Welch Allyn Inc.
7.6 GE Healthcare Inc.
7.7 Mindray Medical International Ltd.
7.8 Siemens Healthcare
7.9 Medtronic Inc.
7.10 Schiller AG.
8.1 Abbreviations
8.2 Sources
8.3 Bibliography
8.4 Disclaimer
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown